Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14608057

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure

Author
GHEORGHIADE, Mihai1 ; GATTIS, A. Wendy A2 ; BARBAGELATA, Alejandro3 ; ADAMS, Kirkwood F4 ; ELKAYAM, Uri5 ; ORLANDI, Cesare6 ; O'CONNOR, Christopher M2
Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV and CHF) Investigators, United States
[1] Northwestern University, Feinberg School of Medicine, Chicago, Ill, United States
[2] Duke Clinical Research Institute, Durham, NC, United States
[3] Instituto de Cordiologia y Cirugia, Buenos Aires, Argentina
[4] University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
[5] University of Southern California, Los Angeles, Calif, United States
[6] Otsuka Maryland Research Institute, Baltimore, Md., United States
Conference title
The Management of Decompensated Heart Failure Resulting in Hospitalization: Proceedings from an Expert Meeting to Review Current Concepts and to Define Future Directions
Conference name
Expert Meeting to Review Current Concepts and to Define Future Directions (Springfield, Virginia 2001-04-20)
Author (monograph)
GHEORGHIADE, Mihai (Editor)1 ; GATTIS, Wendy A (Editor)2 ; ADAMS, Kirkwood F (Editor)3 ; O'CONNOR, Christopher M (Editor)2
[1] Division of Cardiology, Northwestern University, Feinberg School of Medicine, Galter 10-240, 201 E Huron St, Chicago, IL 60611, United States
[2] Duke Clinical Research Institute, Durham, NC, United States
[3] University of North Carolina School of Medicine, Chapel Hill, NC, United States
Source

The American heart journal. 2003, Vol 145, Num 2, pp S51-S54 ; SUP ; ref : 10 ref

CODEN
AHJOA2
ISSN
0002-8703
Scientific domain
Cardiology, blood circulation, phlebology
Publisher
Elsevier, New York, NY
Publication country
United States
Document type
Conference Paper
Language
English
Keyword (fr)
Aggravation Antagoniste Cardiotonique Chimiothérapie Essai thérapeutique contrôlé Etude double insu Homme Hospitalisation Indice gravité Insuffisance cardiaque Pronostic Tolvaptan Traitement Vasopressine Appareil circulatoire pathologie Cardiopathie
Keyword (en)
Aggravation Antagonist Cardiotonic agent Chemotherapy Controlled therapeutic trial Double blind study Human Hospitalization Severity score Heart failure Prognosis Tolvaptan Treatment Vasopressin Cardiovascular disease Heart disease
Keyword (es)
Agravación Antagonista Cardiotónico Quimioterapia Ensayo terapéutico controlado Estudio doble ciego Hombre Hospitalización Indicio gravedad Insuficiencia cardíaca Pronóstico Tolvaptán Tratamiento Vasopresina Aparato circulatorio patología Cardiopatía
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F01 Cardiotonic agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
14608057

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web